Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Abbott Faces Regulatory Scrutiny on Libre Sensors as Insider Buying and New AFib Data Emerge
Abbott shares rose 1.6% to $110.83 Friday but remain 21.5% below their 52-week high. The FDA updated a Class I recall for FreeStyle Libre 3 sensors, citing 860 serious injuries and seven deaths, while an insider purchased 10,000 shares.
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.
Shell Announces Auditor Switch, Kazakhstan Investment Pause Amid Ongoing Buybacks
Shell has selected PwC as its new auditor starting in 2027 and will halt new investments in Kazakhstan due to legal disputes. The company continues its share repurchase program.
IHC Issues Phishing Alert as Shares Hold Steady Near 400 Dirhams
International Holding Company warns investors of fraudulent emails using its branding, while its stock trades flat at 399.60 dirhams. UAE equities edged higher amid focus on geopolitics and oil.
Netflix Gains as DOJ Expands Warner Deal Scrutiny; Hastings Files Share Transfer
Netflix shares closed 1.6% higher at $82.20 amid a deepening Justice Department antitrust review of its $82.7 billion Warner Bros Discovery acquisition. Director Reed Hastings reported transferring 241,944 shares via a family trust.
FDA Crackdown on Compounded Weight-Loss Drugs Boosts Eli Lilly Shares
Eli Lilly stock gained 3.7% after FDA signaled action against telehealth firm Hims & Hers over $49 compounded weight-loss alternatives. Regulatory uncertainty continues to impact obesity drug market valuations.